Stock·NYSE·Consumer Defensive
e.l.f. Beauty, Inc. (ELF)
- Market cap
- $6.70B
- P/E
- 110.34
- Dividend yield
- 0.00%
- Street target
- $112.00median of 18 analysts
- 52-week range
- $48.82 $137.52
The short version
Where ELF stands today, in four lines, and what CleaRank Financial AI makes of it.
ELF at a glance
e.l.f. Beauty, Inc. (ELF): Buy, 71/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($101.76 and $79.74).
- Insiders Insiders sold $104.2M and bought $465K over the last 18 months.
- Valuation P/E of 110.3 against 24.2 for the Consumer Defensive sector: a premium to peers (+356%).
Figures as of October 17, 2026.
CleaRank Financial AI
CleaRank rates e.l.f.
Beauty, Inc. (ELF) Buy, with a model score of 71/100. The trend lifts the score most: the price is 42.38% above its 200-day average and 11.57% above its 50-day average, and the 50-day average is 27.62% above the 200-day. Valuation holds it back most: the P/E of 110.34 is 355.9% above the sector median (a premium to peers) and the P/S of 3.62 is 64.5% above the sector median. The 50-day average stands at $101.76 and the 200-day at $79.74. Over the past year the price fell 16.42%.
Only on CleaRank
Figures we compute ourselves from ELF's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $113.54 is 11.6% above the 50-day simple moving average of $101.76.Price above its 200-day average ›
The price is 42.4% above the 200-day simple moving average of $79.74.50-day average above the 200-day ›
The 50-day average ($101.76) is 27.6% above the 200-day average ($79.74), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 73% of its 52-week range, between $48.82 and $137.52.
ELF share price
Pick a period: each tab shows how far ELF has moved over it, to the last close.
Today's trading
Where ELF sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
1/3P/E below the sector median ›
The trailing P/E of 110.34 is 355.9% above the Consumer Defensive median of 24.2.P/S below the sector median ›
The price-to-sales ratio of 3.62 is 64.6% above the sector median of 2.2.Profitable over the last 12 months ›
Net income over the last 12 months was $59.6M on revenue of $1.8B, a net margin of 3.4%.
Key statistics
The headline figures for ELF.
As of October 17, 2026, ELF trades at $113.54, with a market value of $6.70B and a P/E ratio of 110.34.
What the numbers say
CleaRank Financial AI's reading of ELF's valuation, growth and risks.
e.l.f. Beauty, Inc. (ELF) trades at a trailing P/E of 110.34, 355.9% above the Consumer Defensive median of 24.2, which the peer comparison on this page rates as a premium to peers. Measured against sales, the P/S of 3.62 is 64.5% above the sector median of 2.2. ELF has a market value of $6.7B.
Revenue grew 35.50% over the latest year, which is 30.2 percentage points ahead of the 5.3% median for Consumer Defensive. Profitability shows a net margin of 3.38% and an operating margin of 14.32%, with a return on equity of 6.04%, below the sector median of 19.7%. It also reports debt-to-equity of 0.80.
Day-to-day volatility is the first thing to plan around: ELF has moved 2.60% on an average session. Valuation leaves less margin for error: the P/E of 110.34 is 355.9% above the sector median, a premium to peers. The price is 17.44% below its 52-week high of $137.52. Over the last 18 months, insider sales totalled $104.2M against $465K of purchases; planned sales and tax sales on vesting shares make selling a weaker signal than buying.
ELF against the Consumer Defensive sector
How ELF compares with the median Consumer Defensive stock CleaRank tracks.
Price to earnings vs sector: ELF trades at a significant premium to sector peers (+356%), suggesting market expectations for superior growth or market position.
Return vs SPY: Since May 6, 2025, ELF has gained 67.7% against a gain of 36.6% for SPY.
Performance against SPY
ELF and the Consumer Defensive sector fund over the same days.
Revenue and earnings
How much ELF sells, and how much of it becomes profit.
Revenue growth: Revenue grew 24.6% in FY2026 to $1.6B, from $1.3B a year earlier.
Profit margin: The net margin was 1.6% in FY2026, down from 8.5% the year before.
Profitable: ELF earned $26.3M in FY2026.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 66.5, showing bullish momentum without being overbought.RSI above 50 ›
An RSI of 66.5 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank AI analysis of ELF
The score, the reasoning behind it, and what could move the price next.
e.l.f. Beauty, Inc. (ELF) is in an uptrend: at $113.54, it trades 11.57% above its 50-day average of $101.76 and 42.38% above its 200-day average of $79.74. At 73% of its 52-week range, the price is 17.44% below the 52-week high of $137.52. The 50-day average runs 27.62% above the 200-day average, so the shorter trend is leading the longer one.
Recent gains sit against a weaker longer record: the price rose 21.55% over the past month, rose 54.08% over the past three months and fell 16.42% over the past year. On momentum, the 14-day RSI reads 66.5, in the bullish zone, below the overbought line, with the MACD line positive. The price fell 2.21% in the last session on volume 30.2% above its average.
Rating reaffirmed ›
Baird kept its Outperform rating on October 7, 2026.
Source: Analyst action, Baird, October 7, 2026
No risks flagged.
- Keep an eye on the two closest levels: the 52-week high at $137.52, which sits above the price, and the 20-day EMA at $106.06, which sits below it.
- The 14-day RSI reads 66.5, inside the bullish zone, and the MACD line is positive. Readings above 70 or below 30 signal stretched momentum.
ELF trades above its 50-day and 200-day moving averages ($101.76 and $79.74), which is what makes the trend up; losing the 50-day would be the first warning. The nearest level under the price is the 20-day EMA at $106.06.
The 52-week high at $137.52 is the next level overhead. The RSI sits in the bullish band, which supports the current direction and sits close to the overbought line.
Technical indicators
Momentum and trend for ELF, from its daily closes.
As of October 17, 2026, with ELF at $113.54, its 14-day RSI is 66.5 (showing bullish momentum without being overbought), its 50-day simple moving average is $101.76 and its 200-day is $79.74.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What ELF moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, ELF's 1-year correlation of daily returns is +0.36 with S&P 500 (SPY), +0.34 with Nasdaq 100 (QQQ), +0.20 with Bitcoin (BTC) and +0.04 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
12 of 18 analysts rate it a buy or strong buy, 6 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $112.00 is 1.4% below the price.More buy ratings than three months ago ›
12 of 18 rate it a buy now, against 11 of 18 three months ago.
ELF Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 7, 2026 | Baird | Maintains | Outperform |
| Oct 1, 2026 | Raymond James | Maintains | Strong Buy |
| Sep 17, 2026 | Bernstein | Maintains | Outperform |
| Sep 16, 2026 | B. Riley Securities | Reiterates | Buy |
| Sep 15, 2026 | B of A Securities | Maintains | Buy |
| Sep 14, 2026 | Citigroup | Maintains | Buy |
As of October 17, 2026, 18 Wall Street analysts cover ELF: 12 rate it a buy or strong buy, 6 a hold and 0 a sell or strong sell. Their 12-month price targets range from $65.00 to $127.00, with a median of $112.00, 1.4% below the price of $113.54.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
ELF trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from ELF's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much ELF tends to move, against the market and on its own.
The long record
ELF's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
0/4Average daily move under 2% ›
The price has moved 2.60% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 77.3%, from June 2024 to June 2026; the price is still 47.9% below that peak.Most 1-year holds ended higher ›
59% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $41,317, against $42,058 in the S&P 500 (SPY).
ELF Drawdowns & Recovery
As of October 17, 2026, ELF's worst peak-to-trough fall over the last 10 years with dividends reinvested was -77.3% (June 2024 to June 2026); it is still 47.9% below that peak, and 59% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into ELF in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: ELF trailed the S&P 500 over this period: $41,317 against $42,058.
A $10,000 investment in ELF in October 2016 would be worth about $41,317 today with dividends reinvested, compared with about $42,058 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to ELF, and which have not.
Strongest month, June: an average of +13.69%, up in 8 of 10 years.
Weakest month, March: an average of -8.42%, up in 4 of 10 years.
This month, October: has averaged +0.50%, up in 5 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, ELF's strongest calendar month has been June (average +13.69%, up in 8 of 10 years) and its weakest March (average -8.42%, up in 4 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in ELF, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in ELF today could grow to about $24,312 by 2036 in the base case, with a 90th-percentile outcome near $184,448 and a 10th-percentile outcome around $3,205. Projections are statistical simulations, not guarantees.
ELF Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $162 for ELF by 2030 in the base case, from $114 today (1.4x over 4 years). The 10th-percentile path ends near $44.97. These are outcomes of a Monte Carlo simulation run on ELF's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $65.38 | $124 | $236 | |
| 2028 | $54.80 | $136 | $336 | |
| 2029 | $48.85 | $148 | $450 | |
| 2030 | $44.97 | $162 | $584 | |
| 2031 | $42.24 | $177 | $742 |
Method: a lognormal simulation of ELF's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. ELF is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation.
Insider trading
What the people running the company have bought and sold.
ELF insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $465K on the open market and sold $104.2M.
As of October 17, 2026, ELF insiders reported 66 open-market sales worth $104.2M and 1 open-market purchase worth $465K over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | Tarang P Amin
Chief Executive Officer
|
Sell | 47.0K | $4.9M |
| Oct 1, 2026 | Tarang P Amin
Chief Executive Officer
|
Option | 71.0K | $1.9M |
| Sep 8, 2026 | Mandy J Fields
Chief Financial Officer
|
Sell | 16.1K | $1.7M |
| Sep 8, 2026 | Joshua Allen Franks
Officer
|
Sell | 200 | $22.0K |
| Sep 4, 2026 | Joshua Allen Franks
Officer
|
Grant | 3.3K | - |
| Sep 1, 2026 | Joshua Allen Franks
Officer
|
Sell | 5.5K | $606.3K |
| Sep 1, 2026 | Tarang P Amin
Chief Executive Officer
|
Grant | 20.8K | - |
| Aug 20, 2026 | Charles V Bergh
Director
|
Grant | 1.9K | - |
| Aug 20, 2026 | Tiffany F Daniele
Director
|
Grant | 1.4K | - |
| Aug 20, 2026 | Matthew T Farrell
Director
|
Grant | 1.4K | - |
| Aug 20, 2026 | Maria Ferreras
Director
|
Grant | 1.9K | - |
| Aug 20, 2026 | Lori A. Keith
Director
|
Grant | 2.0K | - |
| Aug 20, 2026 | Lauren Cooks Levitan
Director
|
Grant | 1.4K | - |
| Aug 20, 2026 | Kenneth Mitchell Jr.
Director
|
Grant | 2.0K | - |
| Aug 20, 2026 | Gayle Tait
Director
|
Grant | 1.4K | - |
| Aug 20, 2026 | Maureen C Watson
Director
|
Grant | 1.9K | - |
| Aug 19, 2026 | Joshua Allen Franks
Officer
|
Sell | 5.7K | $571.8K |
| Aug 18, 2026 | Lauren Cooks Levitan
Director
|
Sell | 1.0K | $96.3K |
| Aug 4, 2026 | Kory Marchisotto
Officer
|
Sell | 12.2K | $1.1M |
| Jul 1, 2026 | Tarang P Amin
Chief Executive Officer
|
Sell | 50.2K | $3.9M |
| Jul 1, 2026 | Jennifer Catherine Hartnett
Officer
|
Sell | 25.4K | $2.0M |
| Jul 1, 2026 | Tarang P Amin
Chief Executive Officer
|
Option | 71.0K | $1.9M |
| Jun 10, 2026 | Tarang P Amin
Chief Executive Officer
|
Grant | 48.9K | - |
| Jun 9, 2026 | Tarang P Amin
Chief Executive Officer
|
Sell | 7.0K | $360.7K |
| Jun 9, 2026 | Jennifer Catherine Hartnett
Officer
|
Sell | 4.4K | $224.3K |
| Jun 9, 2026 | Kory Marchisotto
Officer
|
Sell | 4.4K | $224.3K |
| Jun 9, 2026 | Mandy J Fields
Chief Financial Officer
|
Sell | 4.3K | $223.0K |
| Jun 9, 2026 | Scott Kenneth Milsten
General Counsel
|
Sell | 4.2K | $214.5K |
| Jun 9, 2026 | Joshua Allen Franks
Officer
|
Sell | 3.5K | $180.6K |
| Jun 4, 2026 | Tarang P Amin
Chief Executive Officer
|
Sell | 15.8K | $822.2K |
| Jun 4, 2026 | Jennifer Catherine Hartnett
Officer
|
Sell | 10.3K | $535.9K |
| Jun 4, 2026 | Kory Marchisotto
Officer
|
Sell | 8.5K | $442.1K |
| Jun 4, 2026 | Scott Kenneth Milsten
General Counsel
|
Sell | 8.5K | $442.1K |
| Jun 4, 2026 | Mandy J Fields
Chief Financial Officer
|
Sell | 8.5K | $439.6K |
| Jun 4, 2026 | Joshua Allen Franks
Officer
|
Sell | 6.9K | $356.0K |
| Jun 3, 2026 | Tarang P Amin
Chief Executive Officer
|
Grant | 71.2K | - |
| Jun 3, 2026 | Mandy J Fields
Chief Financial Officer
|
Grant | 42.3K | - |
| Jun 3, 2026 | Joshua Allen Franks
Officer
|
Grant | 42.3K | - |
| Jun 3, 2026 | Kory Marchisotto
Officer
|
Grant | 42.3K | - |
| Jun 3, 2026 | Scott Kenneth Milsten
General Counsel
|
Grant | 42.3K | - |
| May 28, 2026 | Lauren Cooks Levitan
Director
|
Sell | 7.7K | $434.4K |
| May 28, 2026 | Lauren Cooks Levitan
Director
|
Option | 7.7K | $63.5K |
| May 26, 2026 | Tarang P Amin
Chief Executive Officer
|
Grant | 37.9K | - |
| Apr 27, 2026 | Kory Marchisotto
Officer
|
Sell | 23.8K | $1.5M |
| Apr 27, 2026 | Mandy J Fields
Chief Financial Officer
|
Sell | 23.7K | $1.5M |
| Apr 27, 2026 | Joshua Allen Franks
Officer
|
Sell | 23.5K | $1.5M |
| Apr 27, 2026 | Jennifer Catherine Hartnett
Officer
|
Sell | 20.8K | $1.3M |
| Apr 24, 2026 | Mandy J Fields
Chief Financial Officer
|
Grant | 42.2K | - |
| Apr 24, 2026 | Joshua Allen Franks
Officer
|
Grant | 42.2K | - |
| Apr 24, 2026 | Jennifer Catherine Hartnett
Officer
|
Grant | 37.0K | - |
| Apr 24, 2026 | Kory Marchisotto
Officer
|
Grant | 42.2K | - |
| Apr 1, 2026 | Tarang P Amin
Chief Executive Officer
|
Sell | 52.9K | $3.3M |
| Apr 1, 2026 | Tarang P Amin
Chief Executive Officer
|
Option | 71.0K | $1.9M |
| Feb 20, 2026 | Matthew T Farrell
Director
|
Buy | 5.0K | $464.8K |
| Feb 12, 2026 | Matthew T Farrell
Director
|
Grant | 980 | - |
| Dec 4, 2025 | Tarang P Amin
Chief Executive Officer
|
Sell | 1.5K | $121.5K |
| Dec 4, 2025 | Scott Kenneth Milsten
General Counsel
|
Sell | 906 | $72.3K |
| Nov 24, 2025 | Lauren Cooks Levitan
Director
|
Sell | 3.8K | $269.5K |
| Nov 24, 2025 | Tarang P Amin
Chief Executive Officer
|
Grant | 61.0K | - |
| Nov 24, 2025 | Lauren Cooks Levitan
Director
|
Option | 2.6K | $21.4K |
| Nov 12, 2025 | Tarang P Amin
Chief Executive Officer
|
Grant | 75.1K | - |
| Oct 1, 2025 | Tarang P Amin
Chief Executive Officer
|
Sell | 116.3K | $15.4M |
| Oct 1, 2025 | Tarang P Amin
Chief Executive Officer
|
Option | 194.5K | $3.3M |
| Oct 1, 2025 | Tarang P Amin
Chief Executive Officer
|
Option | 116.3K | $2.0M |
| Sep 17, 2025 | Scott Kenneth Milsten
General Counsel
|
Sell | 15.0K | $2.3M |
| Sep 17, 2025 | Kory Marchisotto
Officer
|
Sell | 10.8K | $1.6M |
| Sep 17, 2025 | Mandy J Fields
Chief Financial Officer
|
Sell | 5.3K | $795.8K |
| Sep 16, 2025 | Joshua Allen Franks
Officer
|
Sell | 7.9K | $1.1M |
| Sep 12, 2025 | Scott Kenneth Milsten
General Counsel
|
Sell | 15.0K | $2.1M |
| Sep 12, 2025 | Kory Marchisotto
Officer
|
Sell | 13.5K | $1.9M |
| Sep 12, 2025 | Scott Kenneth Milsten
General Counsel
|
Option | 15.0K | $402.6K |
| Sep 11, 2025 | Jennifer Catherine Hartnett
Officer
|
Sell | 1.3K | $177.8K |
| Sep 10, 2025 | Scott Kenneth Milsten
General Counsel
|
Sell | 55.6K | $7.5M |
| Sep 10, 2025 | Scott Kenneth Milsten
General Counsel
|
Option | 50.6K | $1.2M |
| Sep 8, 2025 | Mandy J Fields
Chief Financial Officer
|
Sell | 55.7K | $7.6M |
| Aug 28, 2025 | Maureen C Watson
Director
|
Sell | 785 | $100.8K |
| Aug 28, 2025 | Gayle Tait
Director
|
Sell | 565 | $73.6K |
| Aug 21, 2025 | Charles V Bergh
Director
|
Grant | 1.2K | - |
| Aug 21, 2025 | Tiffany F Daniele
Director
|
Grant | 1.2K | - |
| Aug 21, 2025 | Maria Ferreras
Director
|
Grant | 1.2K | - |
| Aug 21, 2025 | Lori A. Keith
Director
|
Grant | 1.7K | - |
| Aug 21, 2025 | Lauren Cooks Levitan
Director
|
Grant | 1.2K | - |
| Aug 21, 2025 | Kenneth Mitchell Jr.
Director
|
Grant | 1.7K | - |
| Aug 21, 2025 | Gayle Tait
Director
|
Grant | 1.6K | - |
| Aug 21, 2025 | Maureen C Watson
Director
|
Grant | 1.6K | - |
| Aug 14, 2025 | Lauren Cooks Levitan
Director
|
Sell | 4.6K | $550.7K |
| Aug 14, 2025 | Lauren Cooks Levitan
Director
|
Option | 3.4K | $28.3K |
| Jun 11, 2025 | Joshua Allen Franks
Officer
|
Sell | 13.2K | $1.6M |
| Jun 11, 2025 | Tarang P Amin
Chief Executive Officer
|
Grant | 185.4K | - |
| Jun 9, 2025 | Tarang P Amin
Chief Executive Officer
|
Grant | 35.4K | - |
| Jun 5, 2025 | Jennifer Catherine Hartnett
Officer
|
Sell | 9.5K | $1.1M |
| Jun 5, 2025 | Tarang P Amin
Chief Executive Officer
|
Sell | 2.4K | $282.9K |
| Jun 5, 2025 | Joshua Allen Franks
Officer
|
Sell | 1.5K | $175.9K |
| Jun 5, 2025 | Kory Marchisotto
Officer
|
Sell | 1.5K | $175.9K |
| Jun 5, 2025 | Mandy J Fields
Chief Financial Officer
|
Sell | 1.5K | $174.9K |
| Jun 5, 2025 | Scott Kenneth Milsten
General Counsel
|
Sell | 1.4K | $168.2K |
| Jun 5, 2025 | Scott Kenneth Milsten
General Counsel
|
Sell | 1.4K | $165.5K |
| Jun 4, 2025 | Tarang P Amin
Chief Executive Officer
|
Sell | 24.5K | $2.8M |
| Jun 4, 2025 | Joshua Allen Franks
Officer
|
Sell | 11.9K | $1.4M |
| Jun 4, 2025 | Kory Marchisotto
Officer
|
Sell | 11.9K | $1.4M |
| Jun 4, 2025 | Scott Kenneth Milsten
General Counsel
|
Sell | 11.9K | $1.4M |
| Jun 4, 2025 | Mandy J Fields
Chief Financial Officer
|
Sell | 11.8K | $1.4M |
| Jun 4, 2025 | Jennifer Catherine Hartnett
Officer
|
Sell | 9.9K | $1.1M |
| Jun 4, 2025 | Lauren Cooks Levitan
Director
|
Sell | 4.7K | $541.4K |
| Jun 4, 2025 | Lauren Cooks Levitan
Director
|
Option | 3.3K | $27.5K |
| Jun 3, 2025 | Maureen C Watson
Director
|
Sell | 3.9K | $445.6K |
| Jun 3, 2025 | Tarang P Amin
Chief Executive Officer
|
Grant | 32.2K | - |
| Jun 3, 2025 | Mandy J Fields
Chief Financial Officer
|
Grant | 19.2K | - |
| Jun 3, 2025 | Joshua Allen Franks
Officer
|
Grant | 19.2K | - |
| Jun 3, 2025 | Jennifer Catherine Hartnett
Officer
|
Grant | 19.2K | - |
| Jun 3, 2025 | Kory Marchisotto
Officer
|
Grant | 19.2K | - |
| Jun 3, 2025 | Scott Kenneth Milsten
General Counsel
|
Grant | 19.2K | - |
| Jun 3, 2025 | Maureen C Watson
Director
|
Option | 3.9K | $7.1K |
| May 29, 2025 | Jennifer Catherine Hartnett
Officer
|
Sell | 18.4K | $2.0M |
| Apr 21, 2025 | Tarang P Amin
Chief Executive Officer
|
Sell | 97.9K | $5.2M |
| Apr 21, 2025 | Joshua Allen Franks
Officer
|
Sell | 51.4K | $2.7M |
| Apr 21, 2025 | Scott Kenneth Milsten
General Counsel
|
Sell | 51.4K | $2.7M |
| Apr 21, 2025 | Kory Marchisotto
Officer
|
Sell | 51.4K | $2.7M |
| Apr 21, 2025 | Mandy J Fields
Chief Financial Officer
|
Sell | 48.2K | $2.6M |
| Apr 21, 2025 | Jennifer Catherine Hartnett
Officer
|
Sell | 23.4K | $1.2M |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.